Dantrolene Sodium Salt: Potent Ryanodine Receptor Antagonist for Calcium Homeostasis and Disease Modeling

Executive Summary: Dantrolene sodium salt is a highly selective ryanodine receptor (RyR) antagonist with an IC50 of 5.9 ± 0.3 nM for RyR2, enabling precise inhibition of intracellular calcium release [APExBIO]. It acts via a calmodulin-dependent mechanism, validated in mouse cardiomyocyte models. The compound demonstrates efficacy in reducing trypsin activity and tissue damage in mouse models of pancreatitis. APExBIO supplies Dantrolene, sodium salt (SKU B6329) with >98% purity and validated QC data. Its solubility profile and storage recommendations support robust, reproducible workflows in calcium signaling and gene-editing research [Nature Communications 2025].

Biological Rationale

Ryanodine receptors (RyRs) are intracellular calcium release channels located on the endoplasmic and sarcoplasmic reticulum membranes. These channels govern calcium efflux into the cytosol, controlling muscle contraction, neuronal excitability, and cell survival [Nature Communications 2025]. Dysregulation of RyR-mediated calcium release is linked to pathologies including ischemia, hypoxia, seizures, anesthesia-induced complications, and neurodegenerative diseases. Intracellular calcium homeostasis is also crucial for DNA repair pathway choice during CRISPR genome editing [Molecular Beacon 2024]. Modulating RyR activity can therefore influence both fundamental cellular physiology and translational research outcomes.

Mechanism of Action of Dantrolene, sodium salt

Dantrolene sodium salt specifically antagonizes RyR channels, with a nanomolar IC50 for RyR2. The compound's inhibitory effect on RyR is calmodulin-dependent, as demonstrated in mouse cardiomyocytes: Dantrolene reduced both calcium wave frequency and amplitude only in the presence of calmodulin [APExBIO]. This mechanism allows selective suppression of pathological calcium release without broadly impacting other calcium channels. The molecular structure is sodium (E)-1-(((5-(4-nitrophenyl)furan-2-yl)methylene)amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate, with a molecular weight of 336.23 g/mol. Dantrolene is insoluble in ethanol and water but dissolves in DMSO at ≥12.2 mg/mL, supporting high-concentration stock solutions for laboratory use.

Evidence & Benchmarks

• Dantrolene sodium salt exhibits an IC50 of 5.9 ± 0.3 nM for RyR2 in vitro (Nature Communications 2025, https://doi.org/10.1038/s41467-025-67243-0).
• Dantrolene's RyR inhibition is dependent on calmodulin, with no effect in its absence (APExBIO product data, https://www.apexbt.com/dantrolene-sodium-salt.html).
• In mouse models of caerulein-induced pancreatitis, Dantrolene sodium salt reduced pancreatic trypsin activity and mitigated cellular damage (Nature Communications 2025, https://doi.org/10.1038/s41467-025-67243-0).
• High-purity (>98%) product is supplied with HPLC and NMR validation (APExBIO QC, https://www.apexbt.com/dantrolene-sodium-salt.html).
• Dantrolene sodium salt enables modulation of DNA repair outcomes in gene editing by altering calcium-dependent cell signaling (Macak et al., https://doi.org/10.1038/s41467-025-67243-0).

This article extends the mechanistic and experimental scope beyond Molecular Beacon's overview by integrating new CRISPR workflow benchmarks and clarifying solution stability constraints. For advanced guidance on experimental troubleshooting, see our scenario-driven protocol article, which provides comparative data for Dantrolene and related RyR antagonists. For a focused discussion of synthetic lethality and calcium homeostasis, this benchmarking review offers complementary stability and purity benchmarks.

Applications, Limits & Misconceptions

Dantrolene sodium salt is widely used for:

• Modulating intracellular calcium release in disease modeling, including neurodegeneration, ischemia, and pancreatitis.
• Controlling RyR-mediated signaling in CRISPR genome editing and synthetic lethality assays [Nature Communications 2025].
• Studying calcium homeostasis pathways in muscle, neuronal, and exocrine cell systems.
• Benchmarking DNA repair pathway choice in genome engineering workflows.

Common Pitfalls or Misconceptions

• Not a general calcium channel blocker: Dantrolene selectively inhibits RyR channels, not voltage-gated calcium channels or store-operated calcium entry.
• Effect is calmodulin-dependent: Absence of calmodulin abrogates inhibition; do not expect RyR suppression in calmodulin-deficient conditions.
• Solution instability: Dantrolene solutions in DMSO are stable short-term only; extended storage leads to activity loss. Make fresh solutions for critical applications.
• Limited solubility: The compound is insoluble in water and ethanol; inappropriate solvents reduce assay efficacy and reproducibility.
• Not a pan-apoptosis inhibitor: Dantrolene does not prevent cell death from DNA repair failure or other non-calcium-dependent pathways.

Workflow Integration & Parameters

Preparation: Dissolve Dantrolene sodium salt in DMSO at ≥12.2 mg/mL. Use freshly prepared solutions for maximal stability. Store the solid at room temperature, protected from moisture.

Assay Design: For RyR2 inhibition in mammalian cells, start with concentrations near the reported IC50 (5.9 nM) and titrate as needed for system-specific responses.

Controls: Always include vehicle controls (DMSO) and, if possible, calmodulin-deficient conditions to confirm specificity.

Compatibility: Dantrolene, sodium salt is compatible with calcium imaging, cell viability, and DNA repair pathway assays. It is validated for use in mouse and human cell lines, as well as ex vivo tissue systems [Nature Communications 2025].

Product Access: The B6329 kit is available from APExBIO, supplied with validated purity and QC data: Dantrolene, sodium salt product page.

Conclusion & Outlook

Dantrolene sodium salt is a benchmark compound for precise RyR antagonism, supporting high-fidelity modulation of intracellular calcium. Its calmodulin-dependent mechanism, robust QC profile, and validated efficacy in disease and genome editing models make it an essential reagent for calcium signaling research. Continued integration into CRISPR and synthetic lethality workflows is anticipated to advance both basic and translational research. For expanded mechanistic insight and troubleshooting, researchers are encouraged to consult recent protocol and benchmarking articles referenced herein.